What is APLS's EasyStocksAI score?

Apellis Pharmaceuticals Inc. (APLS) scores 19 out of 100 on EasyStocksAI's Graham-inspired scoring system. Breakdown: Total Shareholder Yield: 0/25, Return Consistency: 0/25, Return Growth: 0/25, Payment Regularity: 0/25, Revenue Growth: 9/25, Earnings Growth: 0/25, Margin Trend: 2/25, Capital Efficiency: 0/25, P/E vs Sector: 0/25, Graham Ratio Trend: 0/25, Price Stability: 0/25, Earnings Yield: 0/25, 10Y SPY Outperformance: 0/25, 10Y Sector Outperformance: 0/25, Crisis Resilience: 8/25.

Does APLS pay dividends?

Apellis Pharmaceuticals Inc. does not currently pay a regular dividend.

Apellis Pharmaceuticals Inc.'s Graham Number is 3.44. The current price of 18.39 is above the Graham Number.

How does APLS compare to the Health Care sector?

Apellis Pharmaceuticals Inc. has a P/E ratio of 105.22 in the Health Care sector.

insights

EasyStocksAI

APL

APLS

Apellis Pharmaceuticals Inc.

$18.39 arrow_downward $0.99 (5.11%)

AI Score

N/A

Loading chart…

Loading chart...

analytics Financial Highlights

P/E Ratio 105.22

Dividend Yield 0.00%

Graham Number 3.44

Market Cap $2.4B

Div. Increase Years 0

Continuous Years 0

Crises Survived 1

speed Performance Benchmarks

vs S&P 500 (10Y) -334.04%

vs Sector (10Y) -132.51%

speed Market Sentiment

Extreme Fear

OVERALL MARKET CONFIDENCE

show_chart Trend Analysis

Primary Trend

● Neutral

Secondary Trend Bearish

Warning Price dropped below 20-day MA

MA 20

20.82

MA 50

22.09

MA 200

22.48

analytics Sector Comparison (Health Care)

P/E Ratio —

Graham Ratio —

Track APLS and 1,000+ stocks for free

Get scores, alerts, and portfolio tracking — no credit card required.

Start Free →